HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Target Therapeutics Inc.

Division of Boston Scientific Corp.

Latest From Target Therapeutics Inc.

Cardionovum: As DEBs Heat Up, Who Needs The US Market?

German serial entrepreneur Michael Orlowski achieved a successful exit in his first cardiovascular device company, EuroCor, by selling not to a US-based giant, but to an Indian conglomerate, Opto Circuits. His new company, Cardionovum, has developed a next-generation drug-eluting balloon whose novelty rests on a different approach to the coating technology designed to produce better drug-elution. With CE mark in hand, Cardionovum is preparing to launch its products in Europe. The US is a logical next target, but the high cost of clinical trials and the ever-lengthening regulatory approvals process has made the US an even more difficult market to penetrate, forcing companies like Cardionovum to contemplate strategies that bypass or put off a US launch.

Medical Device Europe

Terumo Branches out in Endovascular Devices

Terumo's business to date has been mostly cardiovascular, with a growing US and European business in devices for peripheral vascular disease. But with aspirations to become a truly global player, Terumo officials know they have to expand and round out their product line. The acquisition this month of Orange County, CA-based MicroVention Inc. is an important step in that direction, giving the Japanese giant a foothold in the one vascular business it doesn't have a significant stake in: interventional neuroradiology.
Medical Device

PneumRx Inc.

From two of the people that founded Spinal Concepts Inc., one of the most successful medical device exits of 2003, comes PneumRx Inc., a new company founded to develop a portfolio of products for interventional pulmonology and thoracic surgery.
Medical Device Platform Technologies

Ekos' Long, Hard Road

A stroke therapy company that combines interventional tools, ultrasound, and pharmaceuticals, Ekos has, in its short history, run into just about every problem a medical device start-up can face, from product failures to difficult financings, aborted partnerships to clinical trials that had to be stopped. Ekos isn't quite out of the woods, but it's getting there, and doing so with a strategy that, particularly in its approach to clinical trials, borrows a lot from the pharmaceutical industry.
Medical Device Platform Technologies
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Boston Scientific Corp.
  • Senior Management
  • Robert E McNamara, VP, Fin. & Admin. & CFO
    Timothy Mills, VP, New Bus. Dev.
    Kevin Riley, VP, Worldwide Mktg.
    Abhi Acharya, VP, Reg. & Clinical Affairs
  • Contact Info
  • Target Therapeutics Inc.
    Phone: (510) 440-7700
    47201 Lakeview Blvd.
    Fremont, CA 94538